New formulae for folding catalysts make them multi-purpose enzymes.

Whereas protein disulfide isomerase (PDI) and prolyl isomerase (PPI) are considered as efficient protein folding catalysts, very few large scale processes use them because of economical and technical limitations. PDI and PPI were successfully immobilized on cross-linked agarose beads. PDI inactivation during coupling reaction was overcome by oxidizing active site thiols with dimethylsulfoxide and led to a 64% active enzyme. Alternatively, PPI and PDI biotinylation resulted in 100% and 55-66% active enzymes respectively. The use of these modified catalysts suppresses post-refolding purification and enables the design of biochemical reactors. Several other possible applications are also discussed. (c) 1997 John Wiley & Sons, Inc. Biotechnol Bioeng 56: 645-649, 1997.

Reexamination of hormone-binding properties of protein disulfide-isomerase.

Protein disulfide-isomerase (PDI), an abundant multifunctional protein, has been described as a 3,3',5-triiodo-L-thyronine (T3)-binding protein. As pointed out by several authors, the physiological significance of this hormone-binding property has not been fully addressed. To clarify this point, we have analyzed the T3-binding properties of purified PDI. At equilibrium, T3 binds PDI at two binding sites: first, at a high-affinity site with a Kd of 21 nM and a Bmax of 1.8 x 10(-3) mol T3/mol PDI monomer, and second at a very low affinity site that is unsaturated up to 100 microM T3. Thus, T3 binding is mainly non-specific and the specific part represents only about 0.2% of the protein monomer. Cross-linking experiments at a concentration where mainly specific binding occurs indicate that PDI does not bind L-T3 exclusively; a wide variety of analogs are also bound. Refolding of reduced denatured ribonuclease A by PDI is inhibited by T3 and analogs, and the inhibition profile reflects the binding properties very closely. Since purified PDI displays neither the specificity expected for a physiological receptor, nor significant T3-binding activity, results are discussed in terms of a necessary PDI association with another component to form a T3 receptor.

ATP binding and hydrolysis by the multifunctional protein disulfide isomerase.

We previously reported the ability of protein disulfide isomerase (PDI) to undergo an ATP-dependent autophosphorylation. Our efforts to map the modification site have been hindered by the low abundance and instability of the labeling. Results are presented in this paper on the nature of phospho-PDI, which appears as an intermediate with a half-life of 2.5-8.8 min in an ATPase reaction. ATP binds to PDI with high affinity, Kd 9.66 microM, and the kinetic parameters KmATP and kcat of the ATPase reaction were measured by using a pyruvate kinase-lactate dehydrogenase-coupled assay under various conditions. Strikingly, the ATPase reaction is stimulated in the presence of denatured polypeptides, while the disulfide oxidization activity of PDI is not affected by ATP. However, PDI is known to participate in various unrelated functions in the endoplasmic reticulum, and ATP could be involved in the regulation of one of these. The results are discussed in light of recent findings on ATP-chaperone relationships.

A major phosphoprotein of the endoplasmic reticulum is protein disulfide isomerase.

One of the effects of ATP in the endoplasmic reticulum is to induce the phosphorylation of several proteins among which a 57-kDa protein (pp57) prevails in our labeling conditions. We provide evidence that pp57 is protein disulfide isomerase (PDI), an abundant ubiquitous protein of the endoplasmic reticulum involved in various important cellular functions. This phosphorylation does not result from the activity of a microsomal protein kinase but from an autophosphorylation as described for other microsomal proteins such as chaperones. Phosphoamino acid analysis and cyanogen bromide cleavage indicate that the modification site lies on a threonine residue within the central region of the protein outside the thioredoxin-like domains. For the pure PDI, only the dimer is able to phosphorylate, while some experiments suggest that within the endoplasmic reticulum the phosphorylated form of PDI is mainly mobilized in larger size oligomers. Thus a possible role for this phosphorylation may be to modulate the association of PDI with its different partners.

A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the mu- and kappa-opioid receptors.

The synthesis and characterization of a novel opioid receptor photoaffinity probe [3H]naltrexyl urea phenylazido derivative ([3H]NUPA) is described. In the absence of light, [3H]NUPA binds with high affinity in a reversible and saturable manner to rat brain and guinea pig cerebellum membranes. Dissociation constants and binding capacities (Scatchard plots) are 0.11 nM and 250 fmol/mg of protein for rat brain and 0.24 nM and 135 fmol/mg of protein for guinea pig cerebellum. Competition experiments indicate that this ligand interacts with high affinity at both mu- and kappa-opioid binding sites while exhibiting low affinity at delta sites (Ki = 21 nM). On irradiation, [3H]NUPA incorporates irreversibly into rat brain and guinea pig cerebellum membranes. SDS gel electrophoresis of rat brain membranes reveals specific photolabeling of a 67-kDa molecular mass band. Conversely, a major component of 58 kDa and a minor component of 36 kDa are obtained from [3H]NUPA-labeled guinea pig cerebellum membranes. Different photolabeling patterns are obtained in rat brain (mu/delta/kappa, 4/5/1) and guinea pig cerebellum (mu+delta/kappa, 1,5/8,5) membranes in the presence of selective opioid ligands indicating labeling of mu and kappa sites, respectively. Thus, [3H]NUPA behaves as an efficient photoaffinity probe of mu- and kappa-opioid receptors, which are probably represented by distinct glycoproteins of 67 and 58 kDa, respectively.